[Failure to treat hepatitis B virus infection with adefovir due to early selection of rtA181T mutation].
Rodríguez Dominguez
Mario
M
de la Loma
Gemma Arranz
GA
Moreira Vicente
Victor
V
Mateos Lindemann
Marisa
M
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D024882:Drug Resistance, Viral; D005260:Female; D005838:Genotype; D006509:Hepatitis B / Q000188:drug therapy*; D006511:Hepatitis B Antigens; D006515:Hepatitis B virus / Q000235:genetics* / Q000276:immunology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D063065:Organophosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D010641:Phenotype; D000068698:Tenofovir; D013997:Time Factors; D017211:Treatment Failure
D000998:Antiviral Agents; D006511:Hepatitis B Antigens; D063065:Organophosphonates; C053001:adefovir; D000068698:Tenofovir; D000225:Adenine